Clinical Trial Update: Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2

View source ↗

Summary

A clinical trial evaluating digital biomarkers for multiple sclerosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Research Center for Clinical Neuroimmunology and Neuroscience Basel | Conditions: Multiple Sclerosis | Status: WITHDRAWN